Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Galen Inc.

Latest From Galen Inc.

US FDA's Generic Research May Include EpiPen And Competitors

Agency wants to acquire Auvi-Q and authorized generics for EpiPen and Adrenaclick, potentially for research on whether user interface affects substitutability.

Combination Products Generic Drugs

US FDA's Generic Research May Include EpiPen And Competitors

Agency wants to acquire Auvi-Q and authorized generics for EpiPen and Adrenaclick, potentially for research on whether user interface affects substitutability.

Combination Products Generic Drugs

Deal Watch: AbbVie Bets On Turnstone’s Cancer Immunotherapy Technology

AbbVie takes options on three oncolytic virus immunotherapies under development at Turnstone. Amgen and CytomX swap IP in cancer immunotherapy collaboration, while Nicox and pSivida will team to fight glaucoma and other eye diseases.

Deals Business Strategies

Dealmaking (06/02)

Summarizing the month in European dealmaking.
See All

Company Information

  • Industry
  • Contract Research, Toxicology Testing-CRO
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Galen Inc.
  • Senior Management
  • Contact Info
  • Galen Inc.
    Phone: (212) 679-8686
    381 Park Ave S,
    New York, NY NY10016
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register